Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Anti-PD-1 MAb market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Anti-PD-1 MAbmarket, defines the market attractiveness level of Anti-PD-1 MAb market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Anti-PD-1 MAb industry, describes the types of Anti-PD-1 MAb market, the applications of major players and the market size, and deeply analyzes the current situation of the global Anti-PD-1 MAb market and the development prospects and opportunities of Anti-PD-1 MAb industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Anti-PD-1 MAb market in Chapter 13.
By Player:
Beijing Beigene
Innovent Biologics Inc
Bristol Myers Squibb
Hengrui Medicine
Merck
Junshi Pharma
By Type:
40mg
100mg
200mg
Others
By End-User:
Melanoma Patients
Lung Cancer Patients
Lymphoma Patients
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Anti-PD-1 MAb Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Anti-PD-1 MAb Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Anti-PD-1 MAb Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Anti-PD-1 MAb Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Anti-PD-1 MAb Market Analysis and Outlook to 2022
-
7.1 Global Anti-PD-1 MAb Consumption (2017-2022)
-
7.2 United States Anti-PD-1 MAb Consumption (2017-2022)
-
7.3 Europe Anti-PD-1 MAb Consumption (2017-2022)
-
7.4 China Anti-PD-1 MAb Consumption (2017-2022)
-
7.5 Japan Anti-PD-1 MAb Consumption (2017-2022)
-
7.6 India Anti-PD-1 MAb Consumption (2017-2022)
-
7.7 South Korea Anti-PD-1 MAb Consumption (2017-2022)
8 Region and Country-wise Anti-PD-1 MAb Market Analysis and Outlook to 2028
-
8.1 Global Anti-PD-1 MAb Consumption Forecast (2022-2028)
-
8.2 United States Anti-PD-1 MAb Consumption Forecast (2022-2028)
-
8.3 Europe Anti-PD-1 MAb Consumption Forecast (2022-2028)
-
8.4 China Anti-PD-1 MAb Consumption Forecast (2022-2028)
-
8.5 Japan Anti-PD-1 MAb Consumption Forecast (2022-2028)
-
8.6 India Anti-PD-1 MAb Consumption Forecast (2022-2028)
-
8.7 South Korea Anti-PD-1 MAb Consumption Forecast (2022-2028)
9 Global Anti-PD-1 MAb Market Outlook by Types and Applications to 2022
-
9.1 Global Anti-PD-1 MAb Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global 40mg Consumption and Growth Rate (2017-2022)
-
9.1.2 Global 100mg Consumption and Growth Rate (2017-2022)
-
9.1.3 Global 200mg Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Anti-PD-1 MAb Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Melanoma Patients Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Lung Cancer Patients Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Lymphoma Patients Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Consumption and Growth Rate (2017-2022)
10 Global Anti-PD-1 MAb Market Outlook by Types and Applications to 2028
-
10.1 Global Anti-PD-1 MAb Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global 40mg Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global 100mg Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global 200mg Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Anti-PD-1 MAb Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Melanoma Patients Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Lung Cancer Patients Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Lymphoma Patients Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Anti-PD-1 MAb Import and Export Analysis (Top 5 Countries)
-
11.1 Global Anti-PD-1 MAb Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Anti-PD-1 MAb Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Anti-PD-1 MAb Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Anti-PD-1 MAb Market Competitive Analysis
-
14.1 Beijing Beigene
-
14.1.1 Beijing Beigene Company Details
-
14.1.2 Beijing Beigene Anti-PD-1 MAb Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Beijing Beigene Anti-PD-1 MAb Product and Service
-
14.2 Innovent Biologics Inc
-
14.2.1 Innovent Biologics Inc Company Details
-
14.2.2 Innovent Biologics Inc Anti-PD-1 MAb Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Innovent Biologics Inc Anti-PD-1 MAb Product and Service
-
14.3 Bristol Myers Squibb
-
14.3.1 Bristol Myers Squibb Company Details
-
14.3.2 Bristol Myers Squibb Anti-PD-1 MAb Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Bristol Myers Squibb Anti-PD-1 MAb Product and Service
-
14.4 Hengrui Medicine
-
14.4.1 Hengrui Medicine Company Details
-
14.4.2 Hengrui Medicine Anti-PD-1 MAb Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Hengrui Medicine Anti-PD-1 MAb Product and Service
-
14.5 Merck
-
14.5.1 Merck Company Details
-
14.5.2 Merck Anti-PD-1 MAb Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Merck Anti-PD-1 MAb Product and Service
-
14.6 Junshi Pharma
-
14.6.1 Junshi Pharma Company Details
-
14.6.2 Junshi Pharma Anti-PD-1 MAb Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Junshi Pharma Anti-PD-1 MAb Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Anti-PD-1 MAb
-
Figure Anti-PD-1 MAb Picture
-
Table Global Anti-PD-1 MAb Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anti-PD-1 MAb Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anti-PD-1 MAb Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Anti-PD-1 MAb Consumption by Country (2017-2022)
-
Figure United States Anti-PD-1 MAb Consumption and Growth Rate (2017-2022)
-
Table Europe Anti-PD-1 MAb Consumption and Growth Rate (2017-2022)
-
Figure China Anti-PD-1 MAb Consumption and Growth Rate (2017-2022)
-
Figure Japan Anti-PD-1 MAb Consumption and Growth Rate (2017-2022)
-
Figure India Anti-PD-1 MAb Consumption and Growth Rate (2017-2022)
-
Figure South Korea Anti-PD-1 MAb Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-PD-1 MAb Consumption Forecast by Country (2022-2028)
-
Figure United States Anti-PD-1 MAb Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Anti-PD-1 MAb Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Anti-PD-1 MAb Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Anti-PD-1 MAb Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Anti-PD-1 MAb Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Anti-PD-1 MAb Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 40mg Consumption and Growth Rate (2017-2022)
-
Figure Global 100mg Consumption and Growth Rate (2017-2022)
-
Figure Global 200mg Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Melanoma Patients Consumption and Growth Rate (2017-2022)
-
Figure Global Lung Cancer Patients Consumption and Growth Rate (2017-2022)
-
Figure Global Lymphoma Patients Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global 40mg Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 100mg Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 200mg Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Melanoma Patients Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lung Cancer Patients Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lymphoma Patients Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Anti-PD-1 MAb Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Anti-PD-1 MAb Export by Region (Top 5 Countries) (2017-2028)
-
Table Beijing Beigene (Foundation Year, Company Profile and etc.)
-
Table Beijing Beigene Anti-PD-1 MAb Sales, Price, Value and Gross Profit (2017-2022)
-
Table Beijing Beigene Anti-PD-1 MAb Product and Service
-
Table Innovent Biologics Inc (Foundation Year, Company Profile and etc.)
-
Table Innovent Biologics Inc Anti-PD-1 MAb Sales, Price, Value and Gross Profit (2017-2022)
-
Table Innovent Biologics Inc Anti-PD-1 MAb Product and Service
-
Table Bristol Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol Myers Squibb Anti-PD-1 MAb Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol Myers Squibb Anti-PD-1 MAb Product and Service
-
Table Hengrui Medicine (Foundation Year, Company Profile and etc.)
-
Table Hengrui Medicine Anti-PD-1 MAb Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hengrui Medicine Anti-PD-1 MAb Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Anti-PD-1 MAb Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Anti-PD-1 MAb Product and Service
-
Table Junshi Pharma (Foundation Year, Company Profile and etc.)
-
Table Junshi Pharma Anti-PD-1 MAb Sales, Price, Value and Gross Profit (2017-2022)
-
Table Junshi Pharma Anti-PD-1 MAb Product and Service
-
